Opdivo shortage — CH supply status & alternatives

Opdivo

—

🇦🇺 AUST R 318057 · Bristol-Myers Squibb Australia Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇨🇭 CH

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Opdivo
Therapeutic category	Auto-created by Swissmedic scraper
Controlled substance	No
Marketing-authorisation holders	Bristol-Myers Squibb Australia Pty Ltd, E.R. Squibb & Sons, L.L.C., Bristol-Myers Squibb Pharma EEIG, BRISTOL-MYERS SQUIBB CANADA

Registrations on file	8

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Verified timeline regulator events

🇨🇭 1 July 2026

medium reported

🇨🇭 28 June 2026

medium reported

🇨🇭 27 June 2026

medium reported

🇨🇭 26 June 2026

medium reported

🇨🇭 22 June 2026

medium reported

🇨🇭 21 June 2026

medium reported

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders8 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
OPDIVO nivolumab	240 mg	—	🇦🇺 AU	Bristol-Myers Squibb Australia Pty Ltd	Active
Opdivo Qvantig	2000; 120U/mL; mg/mL	injection	🇺🇸 US	E.R. Squibb & Sons, L.L.C.	Active
OPDIVO	10mg/mL	injection	🇺🇸 US	E.R. Squibb & Sons, L.L.C.	Active
OPDIVO nivolumab	40 mg	—	🇦🇺 AU	Bristol-Myers Squibb Australia Pty Ltd	Active
OPDIVO nivolumab	100 mg	—	🇦🇺 AU	Bristol-Myers Squibb Australia Pty Ltd	Active
Opdivo	—	—	🌐 EU	Bristol-Myers Squibb Pharma EEIG	Active
OPDIVO	—	solution	🇨🇦 CA	BRISTOL-MYERS SQUIBB CANADA	Active
Opdivo Sc	—	solution	🇨🇦 CA	BRISTOL-MYERS SQUIBB CANADA	Active

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.